Sign inGet started

Cameron Kevin J

Insider CIK 1398422 · KERX Director · CUTR Director · NONE President and CEO

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
NONE Ionetix Corp / DE / A Award deriv2026-10-232026-10-271,025,600— $01,025,600SEC↗
NONE Ionetix Corp / DE / A Award deriv2026-04-092026-05-13334,266— $0334,266SEC↗
NONE Ionetix Corp / DE / A Award deriv2026-04-092026-05-13162,955— $0162,955SEC↗
NONE Ionetix Corp / DE / A Award deriv2026-04-092026-05-13162,955— $0162,955SEC↗
NONE Ionetix Corp / DE / A Award deriv2026-04-092026-05-13162,955— $0162,955SEC↗
NONE Ionetix Corp / DE / A Award deriv2026-04-092026-05-13162,955— $0162,955SEC↗
NONE Ionetix Corp / DE / A Award deriv2026-04-092026-05-13501,400— $0501,400SEC↗
NONE Ionetix Corp / DE / A Award2026-04-092026-05-135,306,782— $05,306,782SEC↗
NONE Ionetix Corp / DE / A Award2026-04-092026-05-13205,932— $0205,932SEC↗
NONE Ionetix Corp / DE / A Award2026-04-092026-05-13206,209— $0206,209SEC↗
CUTR CUTERA INC A Award deriv2024-10-242024-11-0520,000— $045,327SEC↗
CUTR CUTERA INC D To issuer deriv2024-07-152024-07-1725,327— $00SEC↗
CUTR CUTERA INC A Award deriv2024-07-152024-07-1725,327— $025,327SEC↗
CUTR CUTERA INC A Award deriv2023-05-192023-05-3025,327— $025,327SEC↗
KERX KERYX BIOPHARMACEUTICALS I D To issuer deriv2018-12-122018-12-13290,000— $00SEC↗
KERX KERYX BIOPHARMACEUTICALS I D To issuer2018-12-122018-12-13186,666— $00SEC↗
KERX KERYX BIOPHARMACEUTICALS I A Award deriv2018-06-302018-07-1230,000— $030,000SEC↗
KERX KERYX BIOPHARMACEUTICALS I A Award2018-06-302018-07-1210,000— $0186,666SEC↗
KERX KERYX BIOPHARMACEUTICALS I S Sale2018-06-182018-06-191,667$4.98 $8.3K176,666SEC↗
KERX KERYX BIOPHARMACEUTICALS I M Exercise deriv2018-06-152018-06-1810,000— $00SEC↗
KERX KERYX BIOPHARMACEUTICALS I M Exercise2018-06-152018-06-1810,000$0.48 $4.8K178,333SEC↗
KERX KERYX BIOPHARMACEUTICALS I S Sale2018-05-292018-05-311,667$5.22 $8.7K168,333SEC↗
KERX KERYX BIOPHARMACEUTICALS I A Award deriv2017-06-092017-06-2030,000— $030,000SEC↗
KERX KERYX BIOPHARMACEUTICALS I A Award2017-06-092017-06-2010,000— $0170,000SEC↗
KERX KERYX BIOPHARMACEUTICALS I A Award deriv2016-05-262016-05-2730,000— $030,000SEC↗
KERX KERYX BIOPHARMACEUTICALS I A Award2016-05-262016-05-2710,000— $0160,000SEC↗
KERX KERYX BIOPHARMACEUTICALS I A Award deriv2015-06-172015-06-1830,000— $030,000SEC↗
KERX KERYX BIOPHARMACEUTICALS I A Award2015-06-172015-06-1810,000— $0150,000SEC↗
KERX KERYX BIOPHARMACEUTICALS I A Award deriv2014-06-242014-06-2630,000— $030,000SEC↗
KERX KERYX BIOPHARMACEUTICALS I A Award2014-06-242014-06-2610,000— $0140,000SEC↗
KERX KERYX BIOPHARMACEUTICALS I A Award deriv2013-06-192013-06-2125,000— $025,000SEC↗
KERX KERYX BIOPHARMACEUTICALS I A Award2013-06-192013-06-2115,000— $0130,000SEC↗
KERX KERYX BIOPHARMACEUTICALS I A Award deriv2012-06-202012-06-2225,000— $025,000SEC↗
KERX KERYX BIOPHARMACEUTICALS I A Award2012-06-202012-06-2215,000— $0115,000SEC↗